Generic Substitution Noninterference Act
Summary
Generic Substitution Noninterference Act This bill prohibits drug manufacturers from helping or directing health care providers to limit prescriptions to brand-name drugs when generic versions are available. The Federal Trade Commission and states may enforce this bill through civil actions.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2022
Committee Review
Floor Vote
President
Introduced Apr 7, 2022
Last action Nov 1, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Nov 1, 2022
Committee
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
lower
Apr 7, 2022
Committee
Referred to the House Committee on the Judiciary.
lower
Apr 7, 2022
Introduced
Introduced in House
lower
1 primary · 7 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 7473
Scope: US
Hi! I can help you understand HR 7473. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline